Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Assets: 2020-2025

Historic Assets for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $85.2 million.

  • Journey Medical's Assets rose 33.02% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.2 million, marking a year-over-year increase of 33.02%. This contributed to the annual value of $80.2 million for FY2024, which is 4.41% up from last year.
  • As of Q3 2025, Journey Medical's Assets stood at $85.2 million, which was up 4.97% from $81.2 million recorded in Q2 2025.
  • Journey Medical's 5-year Assets high stood at $120.9 million for Q1 2022, and its period low was $64.0 million during Q3 2024.
  • Over the past 3 years, Journey Medical's median Assets value was $76.8 million (recorded in 2023), while the average stood at $76.0 million.
  • As far as peak fluctuations go, Journey Medical's Assets spiked by 87.42% in 2021, and later slumped by 39.05% in 2023.
  • Journey Medical's Assets (Quarterly) stood at $97.3 million in 2021, then climbed by 8.10% to $105.2 million in 2022, then dropped by 26.92% to $76.8 million in 2023, then increased by 4.41% to $80.2 million in 2024, then spiked by 33.02% to $85.2 million in 2025.
  • Its Assets stands at $85.2 million for Q3 2025, versus $81.2 million for Q2 2025 and $85.0 million for Q1 2025.